Try our Advanced Search for more refined results
Securities
-
March 25, 2026
EV Co. Investors Get Final OK Of $13.3M Deal, Atty Fees
Investors in bankrupt electric vehicle company Arrival have gotten final approval for their nearly $13.3 million deal ending claims the company touted a purportedly profitable business plan as it went public via merger with a special purpose acquisition company only to scale back its projections within a year of the merger announcement.
-
March 25, 2026
Ex-Nikola CEOs Can't Get Bankruptcy Pause For Investor Suit
Former CEOs of bankrupt electric-truck maker Nikola Corp. can't hit pause on proposed investor class action claims they face while related claims against the company are stayed amid its bankruptcy proceedings, an Arizona federal judge has determined.
-
March 25, 2026
Extreme Networks Must Face Suit Over COVID-Era Demand
A California federal judge rejected Extreme Networks' bid to dismiss a suit alleging it misled investors about its financial prospects and declining client demand during the COVID-19 pandemic, saying the investors adequately pled that the cloud network equipment company engaged in a scheme to inflate revenues through so-called channel-stuffing.
-
March 25, 2026
FINRA Constitutionality Case Belongs In 4th Circ., Judge Says
A North Carolina federal judge has thrown out a lawsuit challenging the constitutionality of the Financial Industry Regulatory Authority's in-house disciplinary process, saying the case belongs before the Fourth Circuit.
-
March 25, 2026
Warren Grills Fed's Ex-BigLaw Supervision Chief On Conflicts
Sen. Elizabeth Warren, D-Mass., on Wednesday asked former Davis Polk & Wardwell LLP veteran Randall Guynn, a recent addition to the Federal Reserve, to explain how he is dealing with potential conflicts of interest stemming from his previous role chairing the BigLaw firm's financial institutions group.
-
March 25, 2026
Paragon 28 Beats Investor Suit Over Inventory Accounting
A Colorado federal judge has permanently tossed a proposed class action against Paragon 28 Inc., which makes products for foot and ankle surgery, and its executives claiming that they misrepresented the company's inventory levels and key financial metrics, finding that the suit fails to plausibly plead that the defendants knowingly made the misleading statements.
-
March 25, 2026
Binance Will Challenge Singapore Arbitration Bid Denial
Binance will appeal a New York federal judge's ruling last month refusing to force users of the platform who accuse the crypto exchange of improperly selling securities to arbitrate their claims before the Singapore International Arbitration Centre.
-
March 25, 2026
Serta Lenders End Trial Over 'Uptier' Ahead Of Summer Ruling
Lenders to Serta Simmons Bedding presented closing arguments in Texas bankruptcy court Wednesday in a trial over damages that investors excluded from the mattress maker's 2020 "uptier" deal say they should be awarded, an issue which the presiding judge expects to decide on in the next few months.
-
March 25, 2026
FSOC Seeks To Rein In Too-Big-To-Fail Labels In Latest Pivot
Federal regulators moved Wednesday to curb their authority to subject large asset managers, insurers and other nonbank firms to heightened, bank-like supervision, proposing guidelines that would reinstitute tougher standards for these too-big-to-fail designations.
-
March 25, 2026
After Overhaul Nixed, FTC, DOJ Mull New Merger Rulemaking
The Federal Trade Commission and the U.S. Department of Justice are not giving up on attempting to overhaul the "insufficient" half-century-old merger notification form after its replacement was just struck down by a Texas federal judge, with the agencies now seeking public comment as they mull "a new rulemaking process."
-
March 25, 2026
Judge Trims SEC Fraud Case Over Cancer Drug Claims
A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.
-
March 25, 2026
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.
-
March 25, 2026
Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post
The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."
-
March 24, 2026
Charlie Javice Can't Get Retrial Based On Clerk Conflicts
A New York federal judge Tuesday shot down a retrial bid from Charlie Javice, who was convicted of conning JPMorgan Chase & Co. into buying her financial aid startup Frank, rejecting her argument that there was a conflict of interest because clerks who worked on the trial accepted jobs with the bank's firm.
-
March 24, 2026
NY Regulator's Fintech Unit Chief Is Ex-BigLaw, CFPB Analyst
New York's financial services regulator announced Tuesday it has promoted one of its own to permanently head up its division responsible for licensing crypto firms and regulating fintech, a job formerly held by the agency's current acting Superintendent Kaitlin Asrow.
-
March 24, 2026
Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal
Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."
-
March 24, 2026
Game Developer Seeks To Toss Suit Over NFT Delay
Game development studio Neon Machine Inc. urged a New York federal court to dismiss a suit brought by an investment fund specializing in virtual "real estate" over the company's alleged failure to timely deliver an unregistered NFT associated with an unreleased game, arguing the delays in developing the game do not warrant a securities fraud suit.
-
March 24, 2026
AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says
A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.
-
March 24, 2026
SEC Casts Doubt On Egan-Jones' Reentry Into Bond Ratings
Egan-Jones Ratings Co. has found itself back under the U.S. Securities and Exchange Commission's microscope 13 years after the agency pulled its permission to rate government bonds, with the SEC recently expressing concern that the company isn't ready to reenter the space.
-
March 24, 2026
FINRA CEO Highlights New Clearinghouse For Cyber Threats
Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.
-
March 24, 2026
2nd Circ. Won't Recharge Solar Panel Co. Investor Suit
The Second Circuit won't revive a proposed investor class action alleging solar panel infrastructure company Array Technologies failed to convey the impact of certain heightened costs stemming from the COVID-19 pandemic.
-
March 24, 2026
Agenus Escapes Investor Fraud Suit Over Cancer Drug
A Massachusetts federal judge on Tuesday tossed securities fraud claims against Agenus Inc., saying the biotech company did not conceal the risk that a colorectal cancer therapy it was developing might face roadblocks.
-
March 24, 2026
Drug Co. Atara Hit With Investor Suit Over FDA Denial
Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.
-
March 24, 2026
11th Circ. 'Looking For Boundaries' In Ponzi Probe Appeal
The Eleventh Circuit appeared conflicted Tuesday over a former CEO's claims that he was wrongly hit with more than $800,000 in penalties after a civil securities complaint into an alleged Ponzi scheme, weighing whether he was properly dinged for three violations over one enterprise.
-
March 24, 2026
Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees
The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.
Expert Analysis
-
Regulatory Rollback And Lingering Limbo: The CFPB In 2025
The Consumer Financial Protection Bureau has implemented significant changes since President Donald Trump took office in January, including dismissing actions with prejudice, withdrawing guidance and rescinding rules, casting the bureau in uncertain light heading into 2026, say attorneys at Mayer Brown.
-
2025 Calif. Banking Oversight Centered On Consumer Issues
The combination of statutory reform, registration mandates and enforcement activity in 2025 signals that California's financial regulatory landscape is focused on consumer protection, particularly in the areas of crypto kiosk fee practices, earned wage access providers and elder fraud, say attorneys at Ropes & Gray.
-
The Major Securities Litigation Rulings And Trends Of 2025
The past 12 months saw increased regulator focus on disclosures concerning artificial intelligence, signs of growing judicial scrutiny at the class certification stage, and shifting regulatory priorities at the U.S. Securities and Exchange Commission — all major developments that may significantly affect securities litigation strategy in 2026 and beyond, say attorneys at Debevoise.
-
The CFTC's Road Ahead Under Newly Confirmed Chair
Michael Selig's Dec. 18 confirmation as U.S. Commodity Futures Trading Commission chair comes at a critical juncture, as the agency is poised to gain oversight over the crypto industry and increase its jurisdictional mandate covering prediction markets, says Elizabeth Lan Davis at Davis Wright.
-
How Fractional GCs Can Manage Risks Of Engagement
As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.
-
SEC Rulemaking Radar: A Reset, A Shift And A Preview Of '26
With major proposals withdrawn and new priorities emerging, forthcoming U.S. Securities and Exchange Commission proposals in 2026 will look to reshape how digital assets are regulated, recalibrate market structure and simplify how small companies go public, says Christopher Grobbel at Goodwin.
-
Changes In Crypto, Cybersecurity Defined NY Banking In 2025
The major takeaways from 2025 in New York banking policy involve updated guidance, regulations and requirements primarily affecting innovation and digital banking, in areas such as cybersecurity, virtual currencies, and buy now, pay later programs, say attorneys at Steptoe.
-
Del. Dispatch: Key 2025 Corporate Cases And Trends To Know
The Delaware corporate legal landscape saw notable changes in 2025, spurred by amendments to the Delaware General Corporation Law, ubiquitous artificial intelligence fervor, boardroom discussion around DExit, record shareholder activism activity and an arguably more expansive view of potential Caremark liability, say attorneys at Fried Frank.
-
Series
Nature Photography Makes Me A Better Lawyer
Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.
-
2025 Brought A New Paradigm For Federal Banking Regulation
A series of thematic shifts defined banking regulation in 2025, including a fundamental reform of prudential supervision, a strategic easing of capital constraints, steps to streamline merger reviews, and a new framework for fair access and entrants seeking to offer banking services, say attorneys at Simpson Thacher.
-
Series
Law School's Missed Lessons: Practical Problem Solving
Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.
-
Crypto In 2025: From Federal Deregulation To State Action
The cryptocurrency enforcement landscape evolved in 2025, marked by federal deregulatory trends and active state attorney general enforcement, creating both opportunity and risk for businesses navigating the digital asset market, say attorneys at Cozen O'Connor.
-
How CFTC Enforcement Shifted In 2025 And What's Next
The U.S. Commodity Futures Trading Commission pivoted sharply under acting Chairman Caroline Pham in 2025, resulting in a pared-back enforcement docket, sweeping policy changes intended to provide greater transparency, and a renewed focus on fraud prevention and maintaining market integrity for the CFTC's core markets, say attorneys at Moore & Van Allen.
-
Opinion
A Uniform Federal Rule Would Curb Gen AI Missteps In Court
To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.
-
Investment Advisers Should Stay Apprised Of New AI Risks
The U.S. Securities and Exchange Commission's recently issued annual examination priorities reiterate a host of regulatory implications for investment advisers using artificial intelligence tools, highlighting that meaningful ongoing due diligence can help mitigate both operational and regulatory surprises amid AI's rapid evolution, says Christopher Mills at Sidley.